about
The singular behavior of a β-type semi-synthetic two branched polypeptide: three-dimensional structure and mode of action.Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses.Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications.Peptide and glycopeptide dendrimer apple trees as enzyme models and for biomedical applications.Glycopeptide dendrimers as Pseudomonas aeruginosa biofilm inhibitors.Dendrimers functionalized with membrane-interacting peptides for viral inhibition.MAP dendrimer elicits antibodies for detecting rat and mouse GH-binding proteins.A high-performance thioredoxin-based scaffold for peptide immunogen construction: proof-of-concept testing with a human papillomavirus epitope.Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems.Multiple antigenic peptide (MAP): a synthetic peptide dendrimer for diagnostic, antiviral and vaccine strategies for emerging and re-emerging viral diseases.Cell penetration: scope and limitations by the application of cell-penetrating peptides.Peptide-Decorated Dendrimers and Their Bioapplications.Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.Epitope mapping of Brugia malayi ALT-2 and the development of a multi-epitope vaccine for lymphatic filariasis.Synthetic peptides derived from an N-terminal domain of the E2 protein of GB virus C in the study of GBV-C/HIV-1 co-infection.Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers.Dendrimer functionalization with a membrane-interacting domain of herpes simplex virus type 1: towards intracellular delivery.Enhancement in deposition and permeation of 5-fluorouracil through human epidermis assisted by peptide dendrimers.Large-scale synthesis and structural analysis of a synthetic glycopeptide dendrimer as an anti-cancer vaccine candidate.Development of peptidyl lysine dendrons: 1,3-dipolar cycloaddition for peptide coupling and antibody recognition.Molecular dynamics simulation of coarse-grained poly(L-lysine) dendrimers.
P2860
Q31140527-8715CCF3-184B-4F95-9B6B-AB53763CC825Q33636333-23358E60-05B3-4636-A526-28C31B846E0FQ33740696-CD44CA5C-37CC-4C35-B411-71753380EF7BQ34139493-1C2AB7C4-69EF-41E5-AA7D-289C504A11B3Q34570412-6EA889CC-7DA2-49BF-95F7-D835D52D5D26Q36617825-AD8982CD-93F1-4924-BF82-159F507117A4Q37351197-CD927054-749D-49D0-8E3B-87D9A01B6B69Q37714750-1ACD1C2C-6C41-48C6-80F0-F036DB09A3B0Q38168361-418C9CC6-46E9-4152-8D6F-9664929F84A6Q38178610-F7BAA7E3-9CDD-439B-B929-F0789B2FCEACQ38238902-0D5C2014-DA82-4FF6-AC0F-1C0D3595A685Q38779839-9C8FEB4D-22D5-4ACF-875D-968128F7524CQ38925952-C310C869-030E-4900-816B-E4D34F36F35CQ39201869-BC418730-0284-413A-BF22-F2494681E719Q39375757-D5B26285-41C7-418D-AFE7-C640C70DAF61Q39541397-6C82B931-6FF8-42BE-A8A1-4F45AC68C900Q45097356-1616C653-8DF8-4648-B355-BC94257E3463Q46347127-1FD07CAE-347C-475D-936A-2CA296857CA7Q48246161-D1CDA6F5-FDE5-447F-99EA-D4DE9A6DFD71Q51045790-8F1A6761-9C49-43E1-AA89-D0924348A2BCQ51517164-B1BAB043-9175-4922-B183-945175F9AB1C
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Peptide dendrimers.
@ast
Peptide dendrimers.
@en
type
label
Peptide dendrimers.
@ast
Peptide dendrimers.
@en
prefLabel
Peptide dendrimers.
@ast
Peptide dendrimers.
@en
P2860
P356
P1476
Peptide dendrimers
@en
P2093
Petr Niederhafner
P2860
P304
P356
10.1002/PSC.721
P577
2005-12-01T00:00:00Z